Principal investigator, Gene Transfer and Immunogenicity Branch
U.S. Food and Drug Administration
Silver Spring, Maryland
Ronit Mazor is a principal investigator in the Gene Transfer and Immunogenicity Branch, Division of Cellular and Gene Therapies in the Office of Tissues and Advanced Therapies (OTAT). This role includes regulatory science as well as
She performed her graduate research studies in the National Institute of Health International Graduate Partnership Program, with a PhD from Tel Aviv University and did her Post-doctoral training in the National Cancer Institute in Bethesda, working on the immunogenicity of therapeutic proteins for cancer therapy.
After a few years in Medimmune/AstraZeneca, Ronit joined CBER and established a lab studying the interaction between the immune system and gene therapy viral vectors, as well as CMC regulatory science.
Disclosure information not submitted.
Monday, October 17, 2022
8:30 AM – 9:00 AM ET